Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Everest Organics Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

6 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Everest Organics Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Everest Organics has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    9 Apr 2025, 3:00PM As of March 2025, 61.09% is owned by Promoters and 38.91% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 59.35% and Fore
  • Everest Organics - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Apr 2025, 11:55AM Enclosed the RTA certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2025.
  • Everest Organics - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

    27 Mar 2025, 11:26AM Intimation of resignation of CS Tanmaya Kumar Jena as Company Secretary and Compliance Officer w.e.f. close of working of hours of March 26, 2025 on a
  • Everest Organics - Receipt Of Trading Approval From BSE Limited

    20 Mar 2025, 10:54AM Receipt of Trading Approval from BSE Limited
  • Everest Organics has submitted to BSE the Shareholding Pattern for the Period Ended January 13, 2025

    17 Mar 2025, 5:50PM As of January 2025, 61.09% is owned by Promoters and 38.91% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 59.35% and Fo
  • Everest Organics - Receipt Of Listing Approval From BSE Limited

    12 Mar 2025, 11:11AM Receipt of Listing Approval from BSE Limited
  • Everest Organics - Intimation Of Korea Drug Master File (KDMF) Approval For Company'S Rabeprazole Sodium API

    18 Feb 2025, 2:55PM Intimation of Korea Drug Master File (KDMF) approval for Company's Rabeprazole Sodium API.
  • Everest Organics - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    13 Feb 2025, 11:06AM Declaration of results of the postal ballot together with scrutinizers report
  • Everest Organics - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    13 Feb 2025, 11:05AM Declaration of Voting Results of Postal Ballot is enclosed
  • Everest Organics Q3 net profit zooms 5600.00% at Rs 1.14 cr

    11 Feb 2025, 6:30PM The company reported standalone net profit of Rs 1.14 crore for the quarter ended December 31, 2024 as compared to Rs 0.02 crore in the same period la
  • Everest Organics - Integrated Filing (Financial)

    11 Feb 2025, 6:28PM Enclosed the Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024
  • Everest Organics - Board Meeting Outcome for Outcome Of The Board Meeting Held Today

    11 Feb 2025, 6:20PM Outcome of the Board Meeting held today is enclosed.
  • Everest Organics - Un-Audited Financial Results For The Quarter And Nine Months Ended December 31, 2024.

    11 Feb 2025, 6:18PM Enclosed the Un-audited financial results for the quarter and nine months ended December 31, 2024
  • Everest Organics - Board Meeting Intimation for Board Meeting Scheduled To Be Held On Tuesday, February 11, 2025.

    5 Feb 2025, 12:00PM EVEREST ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 ,inter alia, to consider an

Key fundamentals

Evaluate the intrinsic value of Everest Organics Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 103.6287 97.2623 85.5772 66.4962 49.3879
Liabilities 103.6287 97.2623 85.5772 66.4962 49.3879
Equity 8 8 8 8 8
Gross Profit 10.9866 0.9298 6.4276 22.8428 19.1636
Net Profit 0.1392 -0.1822 1.1437 13.7149 10.8966
Cash From Operating Activities 16.4201 18.4179 13.7374 13.533 9.7126
NPM(%) 0.07 -0.09 0.57 7.55 6.51
Revenue 197.2412 183.0484 200.0466 181.5668 167.2123
Expenses 186.2546 182.1186 193.619 158.724 148.0486
ROE(%) 0.32 -0.43 2.71 32.49 25.82

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Everest Organics Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 824.20 -1.99 11.65 222.72 1321.50 1.39
Lotus Eye Hospital and Institute Ltd 80.41 -0.74 338.42 811.58 14.01 0.62
Bharat Immunological and Biologicals Corporation Ltd 23.00 -1.41 0.00 1685.10 -39.50 0.00
Astec Lifesciences Ltd 681.00 -1.58 0.00 765.25 -687.11 0.00

Company Info

Everest Organics Limited, a company with its registered office at Hyderabad, was incorporated on 19th February, 1993. The company has subsequently obtained the certificate of commencement of business on 17th March, 1993. The factory of the company is situated at Aroor Village, Sadasivpet Mandal, Medak district, A.P. The unit is eligible for incentives like State Subsidy, Sales Tax deferment and Power Tariff etc., as the unit is being located in Notified Backward Area. The main objects of the company is to carry on the business of manufacturing, selling of bulk drugs and formulations, which are fully set out in its Memorandum and Articles of Association and are also mentioned below in this prospectus. M/s Everest Organics Limited, envisages to set up a project with a total outlay of Rs.1850 lakhs for Manufacturing Bulk Drugs namely; Para Hydroxy Phenyl Clycine (PHPC) (totally an Import substitute), Omeprazole, Ciprofloxacin, at Aroor Village, Sadasivpet Mandal, Medak district, A.P. As per the schedule given in the project appraisal, the plant will go into Commercial Production by the end of September, 1995. However, the management is confident of implementing the project ahead of the timeframe given in the implementation schedule and starting Commercial Production by July, 1995, i.e.; 2 months ahead of schedule. 2020 - Everest Organics successfully develops Remdesivir API

Everest Organics Limited, a company with its registered office at Hyderabad, was incorporated on 19th February, 1993. The company has subsequently obtained the certificate of commencement of business on 17th March, 1993. The factory of the company is situated at Aroor Village, Sadasivpet Mandal, Medak district, A.P. The unit is eligible for incentives like State Subsidy, Sales Tax deferment and Power Tariff etc., as the unit is being located in Notified Backward Area. The main objects of the company is to carry on the business of manufacturing, selling of bulk drugs and formulations, which are fully set out in its Memorandum and Articles of Association and are also mentioned below in this prospectus. M/s Everest Organics Limited, envisages to set up a project with a total outlay of Rs.1850 lakhs for Manufacturing Bulk Drugs namely; Para Hydroxy Phenyl Clycine (PHPC) (totally an Import substitute), Omeprazole, Ciprofloxacin, at Aroor Village, Sadasivpet Mandal, Medak district, A.P. As per the schedule given in the project appraisal, the plant will go into Commercial Production by the end of September, 1995. However, the management is confident of implementing the project ahead of the timeframe given in the implementation schedule and starting Commercial Production by July, 1995, i.e.; 2 months ahead of schedule. 2020 - Everest Organics successfully develops Remdesivir API

Read More

Parent Organisation

Everest Organics Ltd.

Founded

19/02/1993

Managing Director

Dr.Srikakarlapudi Sirisha

NSE Symbol

FAQ

The current price of Everest Organics Ltd is

The 52-week high for Everest Organics Ltd is

The market capitalization of Everest Organics Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Everest Organics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Everest Organics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Everest Organics Ltd shares.

The CEO of Everest Organics Ltd is Dr.Srikakarlapudi Sirisha, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT